Results 231 to 240 of about 51,824 (261)
Some of the next articles are maybe not open access.

Intravenous Valproic Acid Add-On Therapy in Acute Agitation Adolescents With Suspected Substance Abuse: A Report of Six Cases

Clinical Neuropharmacology, 2018
AbstractThe aim of this study was to test efficacy and safety of intravenous (IV) valproate for aggression in children and adolescents with mood or conduct disorder and concomitant substance abuse. Six patients received a 20 mg/kg dose of IV valproic acid as an add-on therapy to their standard therapy with second-generation antipsychotics and ...
Battaglia C.   +4 more
openaire   +3 more sources

Effect of Chronic Substance Abuse on the Neuropsychological Performance of Intravenous Drug Users with a High Prevalence of HIV-1 Seropositivity

American Journal of Epidemiology, 1992
Limited data are available on cognitive performance in populations of intravenous drug users during the early, asymptomatic stages of human immunodeficiency virus type 1 (HIV-1) infection. Between 1988 and 1990, 151 participants from the AIDS Link to Intravenous Experience (ALIVE) Study in Baltimore, Maryland, were evaluated neuropsychologically on a ...
M, Concha   +8 more
openaire   +2 more sources

Intravenous Substance Abuse and a Presacral Mass

JAMA: The Journal of the American Medical Association, 1990
To the Editor.— Intravenous drug abuse in the United States is a pervasive societal problem with a significant risk of infectious complications. In a large series of drug abusers with medical problems, infections were implicated in 27% of the admissions. 1 We report an unusual infectious complication of parenteral drug use.
openaire   +1 more source

A case of cardiac tamponade due to an isolated abscess in the ascending aorta of a pregnant woman with a history of intravenous substance abuse

Forensic Science, Medicine, and Pathology, 2017
We describe the case of a 23-year-old white female, 10-12 weeks pregnant, with a history of intravenous drug use and a recently diagnosed pneumonia, who was found deceased in her bed after a night of sleep. Although postmortem serum toxicology tested positive for alprazolam, tetrahydrocannabinol, and morphine, the ultimate cause of death was determined
Brandy Shattuck, John Livingstone
openaire   +2 more sources

Group A ß-Hemolytic Streptococcal Bacteremia and Intravenous Substance Abuse

Archives of Internal Medicine, 1990
• Over an 18-month period, the incidence of group A β-hemolytic streptococcal bacteremia rose from an average of 2.5 per 10 000 patient discharges to 17.9. A retrospective analysis was performed comparing patients with group A β-hemolytic streptococcal bacteremia during this 18-month period with those who presented over the preceding 36 months. Most of
openaire   +1 more source

[On forensic medical diagnosis and statistical recording of intravenous substance abuse].

Sudebno-meditsinskaia ekspertiza, 2009
An increasingly higher mortality rate due to diseases related to injection drug use is reported in the literature. However, the relevant diagnostic criteria and ICD-10 coding methods are incompletely explicated in the current publications, the proposed approaches are contradictory, and their practical application encounters difficulties.
A P, Shval'b, N A, Tiazhlov
openaire   +1 more source

The substance abuser and home intravenous therapy: above all else, do no harm.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 1993
Home care therapy is being challenged by changes in patient populations and technologic advances. The selection of appropriate candidates for home intravenous therapy is a critical issue faced by health care professionals. This process is more complex when the patient has a history of intravenous drug abuse.
E A, Krzywda, D A, Andris, R K, Ausman
openaire   +1 more source

Group A beta-hemolytic streptococcal bacteremia and intravenous substance abuse. A growing clinical problem?

Archives of internal medicine, 1990
Over an 18-month period, the incidence of group A beta-hemolytic streptococcal bacteremia rose from an average of 2.5 per 10,000 patient discharges to 17.9. A retrospective analysis was performed comparing patients with group A beta-hemolytic streptococcal bacteremia during this 18-month period with those who presented over the preceding 36 months ...
A L, Lentnek, O, Giger, E, O'Rourke
openaire   +1 more source

Home - About - Disclaimer - Privacy